The evolving rationale for early enteral nutrition based on paradigms of multiple organ failure: A personal journey

Nutrition in Clinical Practice

Volumn 24, Issue 3, 2009, Pages 297-304

  Moore, Frederick A ^a   Moore, Ernest E ^b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE;

ANTIINFLAMMATORY ACTIVITY; CLINICAL TRIAL; CRITICAL ILLNESS; ENTERIC FEEDING; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; INTERMETHOD COMPARISON; JEJUNOSTOMY TUBE; MULTIPLE ORGAN FAILURE; PARENTERAL NUTRITION; POSTOPERATIVE INFECTION; PROTEIN MALNUTRITION; RESUSCITATION; REVIEW; SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

CRITICAL CARE; CRITICAL ILLNESS; ENTERAL NUTRITION; HUMANS; MULTIPLE ORGAN FAILURE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS; TIME;

EID: 67149105780     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0884533609336604     Document Type: Review

References (69)

1. Moore FA, Moore EE Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am. 1995 ; 75: 257-277.
2. Moore EE, Jones TN Benefits of immediate jejunostomy feeding after major abdominal trauma-a prospective, randomized study. J Trauma. 1986 ; 26: 874-881. (Pubitemid 17168610)
3. Borlase BC, Moore EE, Moore FA The abdominal trauma index-a critical reassessment and validation. J Trauma. 1990 ; 30: 1340-1344.
4. Jones TN, Moore FA, Moore EE, McCroskey BL Gastrointestinal symptoms attributed to jejunostomy feeding after major abdominal trauma: a critical analysis. Crit Care Med. 1989 ; 17: 1146-1150. (Pubitemid 19276536)
5. Moore FA, Moore EE, Jones TN, McCroskey BL, Peterson VM TEN versus TPN following major abdominal trauma-reduced septic morbidity. J Trauma. 1989 ; 29: 916-923. (Pubitemid 19211381)
6. Moore FA, Moore EE, Kudsk KA, et al. Clinical benefits of an immune-enhancing diet for early postinjury enteral feeding. J Trauma. 1994 ; 37: 607-615. (Pubitemid 24338110)
7. Moore FA, Feliciano DV, Andrassy RJ, et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications: the results of a meta-analysis. Ann Surg. 1992 ; 216: 172-183.
8. Kudsk KA, Croce MA, Fabian TC, et al. Enteral versus parenteral feeding. Ann Surg. 1992 ; 215: 503-513.
9. Kudsk KA, Minard G., Croce MA, et al. A randomized trial of iso-nitrogenous enteral diets after severe trauma. Ann Surg. 1996 ; 224: 531-543.
10. Border JR, Hassett J., LaDuca J., et al. The gut origin septic states in blunt multiple trauma (ISS = 40) in the ICU. Ann Surg. 1987 ; 206: 427-448. (Pubitemid 18020408)
11. Marshall JC, Christou NV, Meakins JL The gastrointestinal tract: the "undrained abscess" of multiple organ failure. Ann Surg. 1993 ; 218: 111-119. (Pubitemid 23229136)
12. Deitch EA, Winterton J., Li MA, Berg R. The gut as a portal of entry for bacteremia. Ann Surg. 1987 ; 205: 681-692.
13. Peterson VM, Moore EE, Jones TN, et al. Total enteral nutrition versus total parenteral nutrition after major torso injury: attenuation of hepatic protein reprioritization. Surgery. 1988 ; 104: 199-207. (Pubitemid 18205323)
14. Moore FA, Moore EE, Poggetti R., et al. Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J Trauma. 1991 ; 31: 629-636.
15. Moore EE, Moore FA, Franciose RJ, Kim FJ, Biffl WL, Banerjee A. The postischemic gut serves as a priming bed for circulating neutrophils that provoke multiple organ failure. J Trauma. 1994 ; 37: 881-877.
16. Moore FA, Sauaia A., Moore EE, Haenel JB, Burch JM, Lezotte DC Postinjury multiple organ failure: a bimodal phenomenon. J Trauma. 1996 ; 40: 501-510. (Pubitemid 126425001)
17. Moore FA, Peterson VM, Moore EE, Rundus C., Poggetti R. Inadequate granulopoiesis after major torso trauma: a hematopoietic regulatory paradox. Surgery. 1990 ; 108: 667-674.
18. Botha AJ, Moore FA, Moore EE, Fontes B., Banerjee A., Peterson VM Postinjury neutrophil priming and activation states: therapeutic challenges. Shock. 1995 ; 3: 157-166.
19. Faist E., Mewes A., Baker CC, et al. Prostaglandin E2 (PGE2) dependent suppression of interleukin alpha (IL-2) production in patients with major trauma. J Trauma. 1987 ; 27: 837-848. (Pubitemid 17163511)
20. Miller-Graziano CL, Szabo G., Griffey K., Mehta B., Kodys K., Catalano D. Role of elevated monocyte transforming growth factor beta (TGF beta) production in posttrauma immunosuppression. J Clin Immunol. 1991 ; 11: 95-102.
21. Ayala A., Lehman DL, Herdon CD, Chaudry IH Mechanism of enhanced susceptibility to sepsis following hemorrhage: interleukin-10 suppression of T-cell response is mediated by eicosanoidinduced interleukin-4 release. Arch Surg. 1994 ; 129: 1172-1178. (Pubitemid 24335968)
22. Cheadle WG, Pemberton RM, Robinson D., Livingston DH, Rodriguez JL, Polk HC Jr. Lymphocyte subset responses to trauma and sepsis. J Trauma. 1993 ; 35: 844-849. (Pubitemid 24018481)
23. Mannick JA, Rodrick ML, Lederer JA The immunologic response to injury. J Am Coll Surg. 2001 ; 193: 237-244. (Pubitemid 32834762)
24. Bone RC Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med. 1996 ; 125: 680-687. (Pubitemid 126450605)
25. Oberholzer A., Oberholzer C., Moldawer LL Sepsis syndromes: understanding the role of innate and acquired immunity. Shock. 2001 ; 16: 83-96. (Pubitemid 33596740)
26. Hotchkiss RS, Karl IE The pathophysiology and treatment of sepsis. N Engl J Med. 2003 ; 348: 138-150. (Pubitemid 36056721)
27. Abraham E., Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med. 2007 ; 35: 2408-2416. (Pubitemid 47476242)
28. Jordan JR, Moore EE, Sarin EL, et al. Arachidonic acid in post-shock mesenteric lymph induces pulmonary synthesis of leukotriene B4. J Appl Physiol. 2008 ; 104: 1161-1166.
29. Moore FA The role of the gastrointestinal tract in postinjury multiple organ failure. Am J Surg. 1999 ; 178: 449-453. (Pubitemid 30058289)
30. Hassoun HT, Kone BC, Mercer DW, Moody FG, Weisbrodt NW, Moore FA Post-injury multiple organ failure: the role of the gut. Shock. 2001 ; 15: 1-10. (Pubitemid 33598153)
31. Moore FA, Weisbrodt NW Gut dysfunction and intolerance to enteral nutrition in critically ill patients. Nestle Nutr Workshop Ser Clin Perform Programme. 2003 ; 8: 149-165.
32. Kozar RA, Weisbrodt NW, Moore FA Gastrointestinal failure. In: Feliciano DV, Mattox KL, Moore EE, eds. Trauma. 6 th ed. New York, NY: McGraw-Hill ; 2008 ;: 1281-1290.
33. Kazamias P., Kotzampassi K., Koufogiannis D., Eleftheriadis E. Influence of enteral nutrition-induced splanchnic hyperemia on the septic origin of splanchnic ischemia. World J Surg. 1998 ; 22: 6-11. (Pubitemid 28027993)
34. Flynn WJ Jr, Gosche JR, Garrison RN Intestinal blood flow is restored with glutamine or glucose suffusion after hemorrhage. J Surg Res. 1992 ; 52: 499-504.
35. Grossie VB Jr, Weisbrodt NW, Moore FA, Moody F. Ischemia/ reperfusion-induced disruption of rat small intestine transit is reversed by total enteral nutrition. Nutrition. 2001 ; 17: 939-943. (Pubitemid 34020659)
36. Nieuwenhuijs VB, Verheem A., van Duijvenbode-Beumer H., et al. The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats. Ann Surg. 1998 ; 228: 188-193. (Pubitemid 30191713)
37. De-Souza DA, Greene LJ Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit Care Med. 2005 ; 33: 1125-1135. (Pubitemid 40638191)
38. Kang W., Kudsk KA Is there evidence that the gut contributes to mucosal immunity in humans ? JPEN J Parenter Enteral Nutr. 2007 ; 31: 246-258. (Pubitemid 46676809)
39. Kang W., Gomez FE, Lan J., Sano Y., Ueno C., Kudsk KA Parenteral nutrition impairs gut-associated lymphoid tissue and mucosal immunity by reducing lymphotoxin Beta receptor expression. Ann Surg. 2006 ; 244: 392-399.
40. Cerra FB, Lehmann S., Konstantinides N., et al. Improvement in immune function in ICU patients by enteral nutrition supplemented with arginine, RNA, and menhaden oil is independent of nitrogen balance. Nutrition. 1991 ; 7: 193-199.
41. Daly JM, Reynolds J., Thom A., et al. Immune and metabolic effects of arginine in the surgical patient. Ann Surg. 1988 ; 208: 512-523. (Pubitemid 18266467)
42. Gottschlich MM, Jenkins M., Warden GD, et al. Differential effects of three enteral dietary regimens on selected outcome variables in burn patients. JPEN J Parenter Enteral Nutr. 1990 ; 14: 225-236. (Pubitemid 20165398)
43. Daly JM, Lieberman MD, Goldfine J., et al. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery. 1992 ; 112: 56-67.
44. McClave SA, Demeo MT, Delegge MH, et al. North American Summit on Aspiration in the critically ill patient: consensus statement. JPEN J Parenter Enteral Nutr. 2002 ; 26 (6 suppl). S80 - S85.
45. Bertolini G., Lapichino G., Radrizzani D., et al. Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med. 2003 ; 29: 834-840. (Pubitemid 36609578)
46. Heyland DK, Novak F., Drover JW, Jain M., Su X., Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA. 2001 ; 286: 944-953. (Pubitemid 33010341)
47. Suchner U., Heyland DK, Peter K. Immune-modulatory actions of arginine in the critically ill. Br J Nutr. 2002 ; 87 (suppl 1). S1212 - S132.
48. Ochoa JB, Makarenkova V., Bansal V. A rational use of immune enhancing diets: when should we use dietary arginine supplementation ? Nutr Clin Pract. 2004 ; 19: 216-225. (Pubitemid 38747819)
49. Ciesla DJ, Moore EE, Johnson JL, Burch JM, Cothren CC, Sauaia A. A 12-year prospective study of postinjury multiple organ failure: has anything changed ? Arch Surg. 2005 ; 140: 432-438.
50. Dombrovskiy VY, Martin AA, Sunderram J., Paz HL Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007 ; 35: 1244-1250. (Pubitemid 46642649)
51. Suliburk J., Helmer K., Moore FA, Mercer D. The gut in systemic inflammatory response syndrome and sepsis: enzyme systems fighting multiple organ failure. Eur Surg Res. 2008 ; 40: 184-189. (Pubitemid 351252926)
52. Mannick JA 15th Annual Semmelweis Lecture Surgical Infection Society-Europe. Injury-induced immune dysfunction: is the lymphocyte irrelevant ? Surg Infect. 2002 ; 3: 297-302. (Pubitemid 36305406)
53. Osuchowski MF, Welch K., Siddiqui J., Remick DG Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/ CARS continuum in sepsis and predict mortality. J Immunol. 2006 ; 177: 1967-1974. (Pubitemid 44092537)
54. Osuchowski MF, Welch K., Yang H., Siddiqui J., Remick DG Chronic sepsis mortality characterized by an individualized inflammatory response. J Immunol. 2007 ; 179: 623-630. (Pubitemid 46986580)
55. Maier B., Lefering R., Lehnert M., et al. Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma. Shock. 2007 ; 28: 668-674. (Pubitemid 350135471)
56. Xiao H., Siddiqui J., Remick DG Mechanisms of mortality in early and late sepsis. Infect Immun. 2006 ; 74: 5227-5235. (Pubitemid 44300441)
57. Van Dissel JT, van Langevelde P., Westendorp RG, Kwappenberg K., Frolich M. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet. 1998 ; 351: 950-953. (Pubitemid 28138469)
58. Gogos CA, Drosou E., Bassaris HP, Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis. 2000 ; 181: 176-180. (Pubitemid 30049046)
59. Rivers EP, Kruse JA, Jacobsen G., et al. The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med. 2007 ; 35: 2016-2024. (Pubitemid 47326436)
60. Kellum JA, Kong L., Fink MP, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007 ; 167: 1655-1663. (Pubitemid 47280347)
61. McClave SA, Chang WK Feeding the hypotensive patient: does enteral feeding precipitate or protect against ischemic bowel ? Nutr Clin Pract. 2003 ; 18: 279-284. (Pubitemid 37517058)
62. Kozar RA, Verner-Cole E., Schultz SG, et al. The immune-enhancing enteral agents arginine and glutamine differentially modulate gut barrier function following mesenteric ischemia/reperfusion. J Trauma. 2004 ; 57: 1150-1156. (Pubitemid 40053807)
63. Sato N., Moore FA, Smith MA, et al. Immune-enhancing enteral nutrients differentially modulate the early proinflammatory transcription factors mediating gut ischemia/reperfusion. J Trauma. 2005 ; 58: 455-461. (Pubitemid 40365802)
64. Sato N., Moore FA, Kone BC, et al. Differential induction of PPAR-γ by luminal glutamine and iNOS by luminal arginine in the rodent postischemic small bowel. Am J Physiol Gastrointest Liver Physiol. 2006 ; 290: G616 - G623.
65. Reeds PJ, Burrin DG Glutamine and the bowel. J Nutr. 2001 ; 131 (9 suppl). 2505S - 2508S. (Pubitemid 32847000)
66. Thomas S., Prabhu R., Balasubramanian KA Surgical manipulation of the intestine and distant organ damage-protection by oral glutamine supplementation. Surgery. 2005 ; 137: 48-55. (Pubitemid 40029375)
67. Blikslager AT, Rhoads JM, Bristol DG, Roberts MC, Argenzio RA Glutamine and transforming growth factor-alpha stimulate extracellular regulated kinases and enhance recovery of villous surface area in porcine ischemic-injured intestine. Surgery. 1999 ; 125: 186-194. (Pubitemid 29076115)
68. McQuiggan M., Kozar R., Sailors RM, Ahn C., McKinley B., Moore F. Enteral glutamine during active shock resuscitation is safe and enhances tolerance of enteral feeding. JPEN J Parenter Enteral Nutr. 2008 ; 32: 28-35.
69. Kozar RA, McQuiggan MM, Moore EE, Kudsk KA, Jurkovich GJ, Moore FA Postinjury enteral tolerance is reliably achieved by a standardized protocol. J Surg Res. 2002 ; 104: 70-75. (Pubitemid 34948335)